Advertisement
Advertisement
TWST
Twist Bioscience Corporation Common Stock
127.22
USDSponsored
+0.37
+0.29%
Sep 11, 15:59 UTC -4
Closed
Pre-Market
126.83
-0.39
-0.31%
TWST Earnings Reports
Positive Surprise Ratio
TWST beat 18 of 32 last estimates.
56%
Next Report
Date of Next Report
Nov 12, 2026
Estimate for Q4 26 (Revenue/ EPS)
$124.80M
/-$0.38
Implied change from Q3 26 (Revenue/ EPS)
+5.43%
/-32.14%
Implied change from Q4 25 (Revenue/ EPS)
+26.05%
/-15.56%
Twist Bioscience Corporation Common Stock earnings per share and revenue
On Aug 03, 2026, TWST reported earnings of -0.56 USD per share (EPS) for Q3 26, missing the estimate of -0.50 USD, resulting in a -11.20% surprise. Revenue reached 118.38 million, compared to an expected 116.78 million, with a 1.37% difference. The market reacted with a +10.39% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 11 analysts forecast an EPS of -0.38 USD, with revenue projected to reach 124.80 million USD, implying an decrease of -32.14% EPS, and increase of 5.43% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Attovia Therapeutics, Inc. Common Stock
Report Date
Sep 02, 2026 For Q2 26
Estimate
-$2.78
Actual
-$4.88
Surprise
-75.25%
Scribe Therapeutics Inc. Common Stock
Report Date
Sep 02, 2026 For Q2 26
Estimate
-$3.03
Actual
-$2.62
Surprise
+13.59%
Anixa Biosciences, Inc.
Report Date
Sep 09, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+8.78%
Immutep Limited - ADR
Report Date
Sep 01, 2026 For Q4 26
Estimate
$0.00
Actual
-$0.02
Surprise
-2,500.00%
Alzamend Neuro, Inc. Common Stock
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.57
Actual
-$0.68
Surprise
-19.05%
FAQ
What were Twist Bioscience Corporation Common Stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Twist Bioscience Corporation Common Stock reported EPS of -$0.56, missing estimates by -11.2%, and revenue of $118.38M, 1.37% above expectations.
How did the market react to Twist Bioscience Corporation Common Stock's Q3 2026 earnings?
The stock price moved up 10.39%, changed from $91.55 before the earnings release to $101.06 the day after.
When is Twist Bioscience Corporation Common Stock expected to report next?
The next earning report is scheduled for Nov 12, 2026.
What are the forecasts for Twist Bioscience Corporation Common Stock's next earnings report?
Based on 11
analysts, Twist Bioscience Corporation Common Stock is expected to report EPS of -$0.38 and revenue of $124.80M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.